Structural variation cooperates with permissive chromatin to control enhancer hijacking-mediated oncogenic transcription.
Structural variation cooperates with permissive chromatin to control enhancer hijacking-mediated oncogenic transcription.
复制标题
DOI:
10.1182/blood.2022017555
复制
发表时间:
2023-07-27
期刊:
影响因子:
20.3
通讯作者:
Xu, Jian
中科院分区:
文献类型:
--
作者:
Botten, Giovanni A.;Zhang, Yuannyu;Dudnyk, Kseniia;Kim, Yoon Jung;Liu, Xin;Sanders, Jacob T.;Imanci, Aygun;Droin, Nathalie;Cao, Hui;Kaphle, Pranita;Dickerson, Kathryn E.;Kumar, Kirthi R.;Chen, Mingyi;Chen, Weina;Solary, Eric;Ly, Peter;Zhou, Jian;Xu, Jian
We describe a multimodal approach for quantitative analysis of transcriptional and structural impacts imposed by structural variants. Enhancer hijacking cooperates with permissive chromatin to activate oncogenic transcription in leukemic genomes. Structural variants (SVs) involving enhancer hijacking can rewire chromatin topologies to cause oncogene activation in human cancers, including hematologic malignancies; however, because of the lack of tools to assess their effects on gene regulation and chromatin organization, the molecular determinants for the functional output of enhancer hijacking remain poorly understood. Here, we developed a multimodal approach to integrate genome sequencing, chromosome conformation, chromatin state, and transcriptomic alteration for quantitative analysis of transcriptional effects and structural reorganization imposed by SVs in leukemic genomes. We identified known and new pathogenic SVs, including recurrent t(5;14) translocations that cause the hijacking of BCL11B enhancers for the allele-specific activation of TLX3 in a subtype of pediatric leukemia. Epigenetic perturbation of SV-hijacked BCL11B enhancers impairs TLX3 transcription, which are required for the growth of t(5;14) leukemia cells. By CRISPR engineering of patient-derived t(5;14) in isogenic leukemia cells, we uncovered a new mechanism whereby the transcriptional output of SV-induced BCL11B enhancer hijacking is dependent on the loss of DNA hypermethylation at the TLX3 promoter. Our results highlight the importance of the cooperation between genetic alteration and permissive chromatin as a critical determinant of SV-mediated oncogene activation, with implications for understanding aberrant gene transcription after epigenetic therapies in patients with leukemia. Hence, leveraging the interdependency of genetic alteration on chromatin variation may provide new opportunities to reprogram gene regulation as targeted interventions in human disease. Structural variants (SVs) are large sequence differences from normal genomes and occur commonly in leukemias and other cancers. Botten et al describe a new approach that combines genome sequencing, chromatin state, and transcriptional signatures to distinguish pathogenic SVs driving leukemogenesis from nonpathogenic passenger events. The authors identify methylation as a barrier to enhancer hijacking–mediated oncogenic transcription arising from SVs and demonstrate the applicability of their tools and model (Orca-Leukemia) in primary samples.
登录
查看更多内容
影响因子:
12.3
作者:
Barseghyan H;Tang W;Wang RT;Almalvez M;Segura E;Bramble MS;Lipson A;Douine ED;Lee H;Délot EC;Nelson SF;Vilain E
通讯作者:
Vilain E
影响因子:
64.5
作者:
Groeschel, Stefan;Sanders, Mathijs A.;Delwel, Ruud
通讯作者:
Delwel, Ruud
影响因子:
82.9
作者:
通讯作者:
--
影响因子:
23.9
作者:
Laugsch, Magdalena;Bartusel, Michaela;Rada-Iglesias, Alvaro
通讯作者:
Rada-Iglesias, Alvaro
影响因子:
13.6
作者:
He, Bing;Gao, Peng;Tan, Kai
通讯作者:
Tan, Kai